{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:51:06Z","timestamp":1760143866039,"version":"build-2065373602"},"reference-count":24,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF20SA0064190"],"award-info":[{"award-number":["NNF20SA0064190"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>This study estimates the age- and sex-specific prevalence of patients receiving urate-lowering therapy (ULT) in Greenland and compares the results with estimates in Denmark. Characteristics of patients receiving ULT in Greenland were compared to age- and sex-matched controls. The study was designed as a cross-sectional case\u2013control study based on nationwide data from medical and population registers in Greenland and Denmark. The prevalence of patients receiving ULT was significantly lower in Greenland (0.55%) compared to Denmark (1.40%) (p &lt; 0.001). In both countries, the prevalence increased with age and was higher among men compared to women. In Greenland, patients receiving ULT were more often overweight, and more frequently received blood glucose-, lipid-, and blood pressure-lowering medicine including diuretics compared to age- and sex-matched controls. The prevalence of patients receiving ULT was significantly lower in Greenland compared to Denmark. Common life-style related risk factors for hyperuricemia and gout were observed frequently among ULT-treated patients compared to controls. Along with an increasing prevalence of lifestyle-related diseases in Greenland, the prevalence of patients receiving ULT may increase in the years to come. More focus on detection and management of hyperuricemia and gout in Greenland is warranted to improve quality of health care.<\/jats:p>","DOI":"10.3390\/ijerph19127247","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T22:00:38Z","timestamp":1655157638000},"page":"7247","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case\u2013Control Study"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-3256","authenticated-orcid":false,"given":"Sidsel Dan","family":"Hull","sequence":"first","affiliation":[{"name":"Department of Public Heath, University of Copenhagen, 1353 Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne Welzel","family":"Andersen","sequence":"additional","affiliation":[{"name":"Queen Ingrid\u2019s Hospital, Nuuk 3900, Greenland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Bengtsson","sequence":"additional","affiliation":[{"name":"Department of Public Heath, University of Copenhagen, 1353 Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Skovgaard","sequence":"additional","affiliation":[{"name":"Queen Ingrid\u2019s Hospital, Nuuk 3900, Greenland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Balslev","family":"Backe","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Greenland, Queen Ingrid\u2019s Hospital, Nuuk 3900, Greenland"},{"name":"Greenland Center for Health Research, Institute of Health and Nature, University of Greenland, Nuuk 3905, Greenland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Lynge","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Greenland, Queen Ingrid\u2019s Hospital, Nuuk 3900, Greenland"},{"name":"Greenland Center for Health Research, Institute of Health and Nature, University of Greenland, Nuuk 3905, Greenland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_2","first-page":"CD009460","article-title":"Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease. Cochrane Kidney and Transplant Group, editor","volume":"10","author":"Sampson","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107991","DOI":"10.1016\/j.diabres.2019.107991","article-title":"Prevalence, incidence, mortality, and quality of care of diagnosed diabetes in Greenland","volume":"160","author":"Backe","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1709257","DOI":"10.1080\/22423982.2019.1709257","article-title":"Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken","volume":"78","author":"Pedersen","year":"2019","journal-title":"Int. J. Circumpolar Health"},{"key":"ref_7","unstructured":"Larsen, C.V.L., Hansen, C.B., Ingemann, C., J\u00f8rgensen, M.E., Olesen, I., S\u00f8rensen, I.K., Koch, A., Backer, V., and Bjerregaard, P. (2021, May 17). Population Survey in Greenland. National Institute of Public Health, (In Danish)."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2337\/diacare.25.10.1766","article-title":"Diabetes and Impaired Glucose Tolerance Among the Inuit Population of Greenland","volume":"25","author":"Jorgensen","year":"2002","journal-title":"Diabetes Care."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1464-5491.2011.03527.x","article-title":"Diabetes in Greenland and its relationship with urbanization: Diabetes and urbanization in Greenland","volume":"29","author":"Witte","year":"2012","journal-title":"Diabet. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1912540","DOI":"10.1080\/22423982.2021.1912540","article-title":"Prevalence of patients treated with antidepressant medicine in Greenland and Denmark: A cross-sectional study","volume":"80","author":"Ingemann","year":"2021","journal-title":"Int. J. Circumpolar Health"},{"key":"ref_11","unstructured":"(2021, April 21). The Danish Health Data Authority. (In Danish)."},{"key":"ref_12","unstructured":"StatBank Greenland (2021, April 21). Population in Districts and Municipalities 1 January 1977\u20132021. Greenland Statistics, (In Danish)."},{"key":"ref_13","unstructured":"Statistics Denmark (2021, April 21). Population Numbers 1st Quartile of the Year According to Area, Sex, Age and Marital Status. Statistics Denmark, (In Danish)."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Winder, M., Owczarek, A.J., Mossakowska, M., Broczek, K., Grodzicki, T., Wierucki, \u0141., and Chudek, J. (2021). Prevalence of Hyperuricemia and the Use of Allopurinol in Older Poles\u2014Results from a Population-Based PolSenior Study. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18020387"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00296-013-2935-5","article-title":"Allopurinol use in a New Zealand population: Prevalence and adherence","volume":"34","author":"Horsburgh","year":"2014","journal-title":"Rheumatol. Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/art.22474","article-title":"Validity of Gout Diagnoses in Administrative Data","volume":"57","author":"Harrold","year":"2007","journal-title":"Arthritis Care Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/rheumatology\/key390","article-title":"Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: A nationwide register-based study","volume":"58","author":"Zobbe","year":"2019","journal-title":"Rheumatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/03009742.2017.1405461","article-title":"Burden of gout in the Nordic region, 1990\u20132015: Findings from the Global Burden of Disease Study 2015","volume":"47","author":"Kiadaliri","year":"2018","journal-title":"Scand. J. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1542930","DOI":"10.1080\/22423982.2018.1542930","article-title":"Prevalence of patients treated with anti-diabetic medicine in Greenland and Denmark. A cross-sectional register study","volume":"77","author":"Meklenborg","year":"2018","journal-title":"Int. J. Circumpolar Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: Prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13075-018-1612-1","article-title":"Obesity, hypertension and diuretic use as risk factors for incident gout: A systematic review and meta-analysis of cohort studies","volume":"20","author":"Evans","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007\u20132008","volume":"125","author":"Zhu","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","article-title":"Comorbidities in patients with gout prior to and following diagnosis: Case-control study","volume":"75","author":"Kuo","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, Weight Change, Hypertension, Diuretic Use, and Risk of Gout in Men: The Health Professionals Follow-up Study","volume":"165","author":"Choi","year":"2005","journal-title":"Arch. Intern. Med."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/12\/7247\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:30:34Z","timestamp":1760139034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/12\/7247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijerph19127247"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19127247","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2022,6,13]]}}}